Sean Bohen - Net Worth and Insider Trading

Sean Bohen Net Worth

The estimated net worth of Sean Bohen is at least $1 Million dollars as of 2025-01-12. Sean Bohen is the PRESIDENT AND CEO of Olema Pharmaceuticals inc and owns about 241,662 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $1 Million. Details can be seen in Sean Bohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Bohen has not made any transactions after 2024-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sean Bohen

To

Sean Bohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean Bohen owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .

Click here to see the complete history of Sean Bohen’s form 4 insider trades.

Insider Ownership Summary of Sean Bohen

Ticker Comapny Transaction Date Type of Owner
OLMA Olema Pharmaceuticals inc 2024-12-11 director & President and CEO

Sean Bohen Latest Holdings Summary

Sean Bohen currently owns a total of 1 stock. Sean Bohen owns 241,662 shares of Olema Pharmaceuticals inc (OLMA) as of December 11, 2024, with a value of $1 Million.

Latest Holdings of Sean Bohen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OLMA Olema Pharmaceuticals inc 2024-12-11 241,662 5.04 1,217,976

Holding Weightings of Sean Bohen


Sean Bohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean Bohen has made a total of 6 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 109,502 shares on December 11, 2024, which brought Sean Bohen around $986,613.

Insider Trading History of Sean Bohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean Bohen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sean Bohen Ownership Network

Ownership Network List of Sean Bohen

No Data

Ownership Network Relation of Sean Bohen

Insider Network Chart

Sean Bohen Owned Company Details

What does Olema Pharmaceuticals inc do?

Who are the key executives at Olema Pharmaceuticals inc?

Sean Bohen is the director & President and CEO of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , Chief Development Officer David C. Myles , and Chief Medical Officer Naseem Zojwalla .

Olema Pharmaceuticals inc (OLMA) Insider Trades Summary

Over the past 18 months, Sean Bohen made 2 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 166,727. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 334,574 shares made by Cyrus Harmon , a net sale of 2,410,761 shares made by G. Walmsley Graham , and a net sale of 70,436 shares made by David C. Myles .

In summary, during the past 3 months, insiders sold 1,616,447 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 700,761 shares, with a net sale of 915,686 shares. During the past 18 months, 6,819,521 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,946,693 shares were bought by its insiders, resulting in a net sale of 3,872,828 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Olema Pharmaceuticals inc Insider Transactions

No Available Data

Sean Bohen Mailing Address

Above is the net worth, insider trading, and ownership report for Sean Bohen. You might contact Sean Bohen via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.